Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase …
G Plewig, WJ Cunliffe, N Binder, K Höschen - Contraception, 2009 - Elsevier
BACKGROUND: The study was conducted to assess the effects of the monophasic
combined oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone …
combined oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone …
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase …
G Plewig, WJ Cunliffe, N Binder, K Höschen - Contraception, 2009 - infona.pl
The study was conducted to assess the effects of the monophasic combined oral
contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate (CMA) 2 …
contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate (CMA) 2 …
[引用][C] Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled …
G PLEWIG, WJ CUNLIFFE, N BINDER… - Contraception …, 2009 - pascal-francis.inist.fr
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate
acne resolution: a randomized, double-blind, placebo-controlled Phase III trial CNRS Inist …
acne resolution: a randomized, double-blind, placebo-controlled Phase III trial CNRS Inist …
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III …
G Plewig, WJ Cunliffe, N Binder, K Höschen - Contraception, 2009 - europepmc.org
Background The study was conducted to assess the effects of the monophasic combined
oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate …
oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate …
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara ) in moderate acne resolution: a randomized, double-blind, placebo-controlled …
G Plewig, WJ Cunliffe, N Binder - Contraception, 2009 - contraceptionjournal.org
Background The study was conducted to assess the effects of the monophasic combined
oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate …
oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate …
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III …
G Plewig, WJ Cunliffe, N Binder… - …, 2009 - pubmed.ncbi.nlm.nih.gov
Background The study was conducted to assess the effects of the monophasic combined
oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate …
oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone acetate …